India And Singapore Create Fast Track For Generics Approval, Lifting Regulatory Process For Some Drugs
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Indian generic drug manufacturers have made another mark on the international arena by gaining faster and broader market access for their products in Singapore
You may also be interested in...
Indian Commerce Minister Speaks Strongly Against EU Drug Seizures
Recent seizures of Indian generic drugs bound for other destinations transiting through European ports are one of many attempts to discredit Indian generic drugs, visiting Indian Commerce & Industry Minister Anand Sharma told reporters in Washington on June 18 during a press briefing
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).